Group One Trading’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20
Closed -$145 8206
2022
Q4
$145 Sell
20
-130
-87% -$1.09K ﹤0.01% 7054
2022
Q3
$1K Buy
+150
New +$2.8K ﹤0.01% 7418
2022
Q1
Sell
-30
Closed -$2K 8979
2021
Q4
$2K Sell
30
-20
-40% -$1.36K ﹤0.01% 7931
2021
Q3
$4K Buy
+50
New +$5.03K ﹤0.01% 7840
2021
Q1
Sell
-60
Closed -$10K 8172
2020
Q4
$10K Buy
+60
New +$9.27K ﹤0.01% 5803

Group One Trading's HARP Position: Q1 2024 in Review

Group One Trading sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 35 shares — an estimated $398 sold.

Group One Trading first reported a position in HARP in Q1 2021 and held it in 10 quarters. The position peaked at $28K in Q1 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

  • Group One Trading reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 35 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $398.
  • Group One Trading first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Group One Trading's Harpoon Therapeutics, Inc. Common Stock position peaked at $28K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.